長江基建集團(01038.HK)年度純利增3.1%至77.48億港元 末期息1.83港元
格隆匯3月15日丨長江基建集團(01038.HK)公佈,截至2022年12月31日止年度,公司營業額為392.36億港元,同比減少3.67%;公司股東應占期內盈利為77.48億港元,同比增長3.10%;基本每股盈利為3.08港元,擬派末期息每股1.83港元。
公吿稱,業績備受利率上升導致財務成本增加(尤其是與通脹掛鈎之財務成本上升)及外幣兑港元走弱所影響。
長江基建的優質基建資產持續展現堅韌實力,帶來按年增長7%的理想貢獻。以業務所在地貨幣計算,基建投資組合的貢獻則按年上升16%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.